Walk through any high school hallway in America. You might notice something that wasn't there a decade ago: the faint, sweet smell of flavored aerosol. It doesn't come from cigarettes. Those have largely disappeared from teen culture. Instead, it comes from easy-to-conceal, pocket-sized electronic devices called e-cigarettes. Vaping in fact, once marketed as a harm-reduction tool for adult smokers, has become one of the most significant public health challenges facing adolescents today.
Vaping is a habit that 1.6 million American students share, and one that doctors warn is far harder to quit than it looks.
getty
The data behind vaping is clear: it poses real health risks and it disproportionately affects young people.
The scale of U.S. youth e-cigarette use is a major issue. According to the 2024 National Youth Tobacco Survey, an estimated 1.63 million middle and high school students, or 5.9%, reported current e-cigarette use. This is a meaningful decline from where it was in 2023 (2.1 million) and its peak in 2019 (5 million).
However, a rising concern is that among students who vape, use intensity has increased sharply. In a separate national study, daily nicotine vaping among youth current vapers rose from 15% in 2020 to 29% in 2024, while unsuccessful quit attempts among daily vapers rose from 28% to 53%.
Vaping’s appeal among young people is driven in part by youth-appealing flavors—candy, fruit and mint varieties, as well as social media content. Among middle and high school students who reported using social media in 2024, nearly three-quarters encountered e-cigarette-related content online.
On the positive side, e-cigarettes are safer than traditional cigarettes. Cigarette smoke contains roughly 7,000 chemicals. Many are carcinogenic. E-cigarettes aerosols also contain toxicants, yet at lower concentrations.
Nevertheless, the evidence increasingly shows that vaping is associated with multiple adverse health effects and is unsafe for youth.The extent of the long-term consequences remains uncertain given how recently these products entered widespread use. A 2026 meta-analysis found that while e-cigarettes were associated with lower risks than cigarettes, when compared to non-use, all disease outcomes showed increased risk.
Nicotine is an immediate concern and is in most e-cigarettes. An issue is that sometimes the concentration far exceeds that of traditional cigarettes. A single pod can contain as much nicotine as an entire pack.
Nicotine is highly addictive and is harmful to the developing brain, which continues maturing until about age 25. Adolescent nicotine exposure has been shown to impair attention, learning, mood regulation and impulse control. Young people who vape are also three to four times more likely to go on to smoke traditional cigarettes compared to teens who never vaped.
Vaping also can cause serious respiratory problems. E-cigarette aerosols are directly toxic to lung cells, inducing both acute and chronic inflammation, impairing immune responses against viruses and bacteria and causing airway hyperresponsiveness (e.g. asthma). Population surveys also link vaping to chronic cough, phlegm, bronchitis, shortness of breath, asthma flares and chronic obstructive pulmonary disease—or COPD.
Severe acute lung injuries have also been documented. EVALI (e-cigarette or vaping product use-associated lung injury) emerged dramatically in 2019 and 2020, resulting in more than 2,800 U.S. hospitalizations and 68 deaths. It was strongly linked to vitamin E acetate used as an additive in THC-containing vaping products.
While EVALI cases have declined since, the episode illustrates the risks of an industry with minimal regulation where manufacturers can add compounds to vaping liquids without safety testing.
The heart health risks are equally concerning. Vaping impairs endothelial function and causes acute hemodynamic changes: higher blood pressure, heart rate and arterial stiffness. Platelet activation and aggregation increase after exposure to both nicotine-containing and nicotine-free aerosols, and long-term use is associated with increased oxidative stress.
With respect to cancer risk, long-term human epidemiological evidence is still limited.
E-cigarette aerosols contain both definite and probable carcinogens, including nicotine-derived nitrosamines, polycyclic aromatic hydrocarbons, heavy metals, and aldehydes like formaldehyde. Mice exposed to e-cigarette aerosol for 54 weeks developed lung cancer and an overgrowth of bladder abnormal cells.
The recent decline in youth vaping shows that policy and enforcement efforts can be effective. But more work is needed.
Regulatory enforcement must be strengthened and sustained. As of March 2026, the FDA had authorized 41 e-cigarette products for sale to adults over age 21. This reflects an attempt to bring order to a chaotic market. After an enforcement action against the brand Elf Bar, its youth market share dropped from 57% to 36% from in 2024. This followed a campaign of warning letters, civil penalties and import alerts.
This shows that targeted regulatory pressure can move the needle. These efforts must continue and expand, particularly targeting unauthorized products and retailers who sell to minors.
Flavor restrictions also deserve serious consideration. Flavored products are a primary driver of youth initiation. Federal and state-level restrictions on flavored e-cigarettes would reduce the appeal of these products to adolescents.
Education and cessation support are also critical. The FDA’s "The Real Cost" campaign reaches approximately 90% of U.S. teens with prevention messaging. Programs like EX Program, a free text-based cessation service from Truth Initiative, have helped more than 780,000 young people attempt to quit vaping. Evidence shows it increases quit rates by 35 to 40% in clinical studies.
Pediatricians and primary care physicians should screen routinely for vaping use and connect young patients with cessation tools, just as they would for cigarette smoking.
Parents and schools also play an essential role. Data show that the majority of middle and high school students who currently vape want to quit. That statistic should give adults hope—and urgency. Open, non-judgmental conversations between parents and teenagers about vaping can reduce initiation and support cessation. School-based programs that emphasize the biology of nicotine addiction, rather than simple scare tactics, tend to be more effective at reaching adolescents skeptical of authority-driven messaging.
Ultimately, the recent downward trend in youth vaping rates is encouraging. Yet more than one-and-a-half million young Americans are still regularly inhaling nicotine and a cocktail of imperfectly understood chemicals into developing lungs. About half of daily youth vapers who tried to quit reported unsuccessful quit attempts.
Today’s evidence demonstrates clearly vaping is linked to multiple adverse health effects, while the full extent of long-term consequences remains uncertain. That uncertainty is itself is part of the public health story of e-cigarettes.
Decades ago, the tobacco industry normalized cigarette smoking among young Americans. The public health consequences shaped generations of disease, disability, and premature death. The e-cigarette industry has leveraged much of the same playbook suggesting their products are somehow different or safer.
The science on long-term vaping health risks is still being written. But the early chapters are troubling enough to demand action, rather than waiting for the full story to emerge.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。